These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 22183941)

  • 21. Nosocomial infections due to multidrug-resistant bacteria in cancer patients: a six-year retrospective study of an oncology Center in Western China.
    Jiang AM; Shi X; Liu N; Gao H; Ren MD; Zheng XQ; Fu X; Liang X; Ruan ZP; Yao Y; Tian T
    BMC Infect Dis; 2020 Jun; 20(1):452. PubMed ID: 32600270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacteremia in Patients With Liver Cirrhosis: Prevalence and Predictors of Multidrug Resistant Organisms.
    Addo Smith JN; Yau R; Russo HP; Putney K; Restrepo A; Garey KW; Sofjan AK
    J Clin Gastroenterol; 2018 Aug; 52(7):648-654. PubMed ID: 29176351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia.
    Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):187-93. PubMed ID: 16105563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resistance patterns among nosocomial pathogens: trends over the past few years.
    Jones RN
    Chest; 2001 Feb; 119(2 Suppl):397S-404S. PubMed ID: 11171776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Community-onset healthcare-related urinary tract infections: comparison with community and hospital-acquired urinary tract infections.
    Aguilar-Duran S; Horcajada JP; Sorlí L; Montero M; Salvadó M; Grau S; Gómez J; Knobel H
    J Infect; 2012 May; 64(5):478-83. PubMed ID: 22285591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial susceptibility of Gram-negative organisms from intraabdominal infections and evolution of isolates with extended spectrum β-lactamases in the SMART study in Spain (2002-2010).
    Cantón R; Loza E; Aznar J; Calvo J; Cercenado E; Cisterna R; Romo FG; Hontangas JL; Calvo CR; Barrenechea AI; Tubau F; Weber I; Yuste P; Cavanillas R;
    Rev Esp Quimioter; 2011 Dec; 24(4):223-32. PubMed ID: 22173194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and antibiotic sensitivity of Danish versus other European bacterial isolates from intensive care and hematology/oncology units.
    Fomsgaard A; Høiby N; Friis HM; Gahrn-Hansen B; Kolmos HJ; Schouenborg P; Korsager B; Tvede M; Gutschik E; Bremmelgaard A
    Eur J Clin Microbiol Infect Dis; 1995 Apr; 14(4):275-81. PubMed ID: 7649189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New antibiotic strategies in patients with cirrhosis and bacterial infection.
    Fernández J; Acevedo J
    Expert Rev Gastroenterol Hepatol; 2015; 9(12):1495-500. PubMed ID: 26465070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nosocomial spontaneous bacterial peritonitis antibiotic treatment in the era of multi-drug resistance pathogens: A systematic review.
    Fiore M; Maraolo AE; Gentile I; Borgia G; Leone S; Sansone P; Passavanti MB; Aurilio C; Pace MC
    World J Gastroenterol; 2017 Jul; 23(25):4654-4660. PubMed ID: 28740354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparative study on nosocomial and community-acquired spontaneous bacterial peritonitis in patients with liver cirrhosis at a university hospital.
    ELshamy RM; Oda MS; Saeed MA; Ramadan RA
    Eur J Gastroenterol Hepatol; 2022 Jun; 34(6):655-663. PubMed ID: 35352700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methicillin-resistant staphylococci (MRS) and extended-spectrum beta-lactamases (ESBL)-producing Enterobacteriaceae in companion animals: nosocomial infections as one reason for the rising prevalence of these potential zoonotic pathogens in clinical samples.
    Wieler LH; Ewers C; Guenther S; Walther B; Lübke-Becker A
    Int J Med Microbiol; 2011 Dec; 301(8):635-41. PubMed ID: 22000738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multidrug-resistant bacteria in hospitalized children: a 5-year multicenter study.
    Raymond J; Nordmann P; Doit C; Vu Thien H; Guibert M; Ferroni A; Aujard Y
    Pediatrics; 2007 Apr; 119(4):e798-803. PubMed ID: 17403822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors for resistance to ceftriaxone and its impact on mortality in community, healthcare and nosocomial spontaneous bacterial peritonitis.
    Ariza X; Castellote J; Lora-Tamayo J; Girbau A; Salord S; Rota R; Ariza J; Xiol X
    J Hepatol; 2012 Apr; 56(4):825-32. PubMed ID: 22173153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997).
    Pfaller MA; Jones RN; Doern GV; Kugler K
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1762-70. PubMed ID: 9661018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intestinal colonization with resistant bacteria: a prognostic marker of mortality in decompensated cirrhosis.
    Pouriki S; Vrioni G; Sambatakou H; Alexopoulou A; Vasilieva L; Mani I; Tsakris A; Dourakis SP
    Eur J Clin Microbiol Infect Dis; 2018 Jan; 37(1):127-134. PubMed ID: 28963603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction in colonization and nosocomial infection by multiresistant bacteria in a neonatal unit after institution of educational measures and restriction in the use of cephalosporins.
    Calil R; Marba ST; von Nowakonski A; Tresoldi AT
    Am J Infect Control; 2001 Jun; 29(3):133-8. PubMed ID: 11391273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of infections in patients with cirrhosis in the context of increasing therapeutic resistance: A systematic review.
    Allaire M; Cadranel JF; Nguyen TTN; Garioud A; Zougmore H; Heng R; Perignon C; Ollivier-Hourmand I; Dao T
    Clin Res Hepatol Gastroenterol; 2020 Jun; 44(3):264-274. PubMed ID: 31706985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology and outcomes of multiple antibiotic-resistant bacterial infection in renal transplantation.
    Linares L; Cervera C; Cofán F; Ricart MJ; Esforzado N; Torregrosa V; Oppenheimer F; Campistol JM; Marco F; Moreno A
    Transplant Proc; 2007 Sep; 39(7):2222-4. PubMed ID: 17889144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiology and microbiological profile comparison between community and hospital acquired infections: A multicenter retrospective study in Lebanon.
    Matta R; Hallit S; Hallit R; Bawab W; Rogues AM; Salameh P
    J Infect Public Health; 2018; 11(3):405-411. PubMed ID: 28970096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patterns of antimicrobial therapy in severe nosocomial infections: empiric choices, proportion of appropriate therapy, and adaptation rates--a multicentre, observational survey in critically ill patients.
    Vogelaers D; De Bels D; Forêt F; Cran S; Gilbert E; Schoonheydt K; Blot S;
    Int J Antimicrob Agents; 2010 Apr; 35(4):375-81. PubMed ID: 20122817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.